US Stock MarketDetailed Quotes

SNTI Senti Biosciences

Watchlist
  • 2.1706
  • +0.0506+2.39%
Close Nov 22 16:00 ET
  • 2.1706
  • 0.00000.00%
Post 20:01 ET
9.96MMarket Cap-139P/E (TTM)

Senti Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.85%-7.87M
38.98%-8.35M
28.35%-11.68M
-50.15%-52.4M
21.86%-7.04M
-51.73%-15.38M
-140.12%-13.68M
-62.08%-16.3M
-0.75%-34.9M
24.77%-9.01M
Net income from continuing operations
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
-22.05%-71.06M
-2.71%-18.72M
10.32%-14.92M
-61.85%-18.7M
-58.55%-18.72M
-5.25%-58.22M
-67.11%-18.22M
Operating gains losses
---2.35M
----
----
-1,596.04%-21.86M
--5.63M
----
----
----
---1.29M
--0
Depreciation and amortization
-19.34%1.46M
21.14%1.47M
57.27%1.46M
38.49%5.43M
56.14%1.47M
76.04%1.82M
29.52%1.21M
-8.02%929K
30.23%3.92M
-8.70%944K
Other non cash items
10,020.56%17.86M
3,073.17%3.66M
-2,551.69%-2.36M
45.90%-5.2M
-357.56%-4.81M
-161.02%-180K
---123K
---89K
-165.21%-9.61M
---1.05M
Change In working capital
622.64%3.05M
171.02%2.39M
104.34%70K
-66.45%4.67M
17.39%5.98M
-120.19%-583K
-84.97%880K
-2,543.94%-1.61M
2,160.81%13.9M
278.83%5.1M
-Change in receivables
98.15%-40K
-183.42%-166K
115.56%21K
-609.16%-929K
401.72%1.16M
-690.11%-2.16M
239.16%199K
-354.72%-135K
66.84%-131K
564.00%232K
-Change in prepaid assets
186.37%4.14M
948.26%4.21M
1,015.17%3.68M
468.20%4.79M
525.98%3.35M
410.75%1.45M
140.57%402K
-5.51%-402K
20.71%-1.3M
977.05%535K
-Change in payables and accrued expense
-93.79%29K
-266.94%-616K
-63.28%-2.56M
-80.99%426K
75.15%1.16M
-59.18%467K
-81.68%369K
0.70%-1.57M
14.51%2.24M
130.34%660K
-Change in other current liabilities
-12.27%-1.03M
-742.48%-983K
-207.26%-946K
-96.57%484K
-87.53%370K
-128.64%-921K
-97.23%153K
-63.61%882K
1,342.66%14.13M
1,920.86%2.97M
-Change in other working capital
-107.89%-46K
73.66%-64K
67.60%-127K
89.35%-110K
-108.29%-58K
179.43%583K
55.49%-243K
13.47%-392K
-156.39%-1.03M
275.00%700K
Cash from discontinued investing activities
Operating cash flow
48.85%-7.87M
38.98%-8.35M
28.35%-11.68M
-50.15%-52.4M
21.86%-7.04M
-51.73%-15.38M
-140.12%-13.68M
-62.08%-16.3M
-0.75%-34.9M
24.77%-9.01M
Investing cash flow
Cash flow from continuing investing activities
-99.72%60K
0
99.84%-15K
136.70%30.08M
100.21%101K
248.88%21.14M
262.80%18.33M
-28.69%-9.5M
-1,378.60%-81.96M
-1,132.57%-49.12M
Net PPE purchase and sale
103.23%60K
--0
99.77%-15K
71.16%-11.93M
101.18%101K
86.92%-1.86M
67.42%-3.67M
11.83%-6.51M
-646.42%-41.37M
-114.13%-8.53M
Net investment purchase and sale
--0
--0
--0
203.51%42.01M
--0
--23M
--22M
---2.99M
---40.59M
---40.59M
Cash from discontinued investing activities
Investing cash flow
-99.72%60K
--0
99.84%-15K
136.70%30.08M
100.21%101K
248.88%21.14M
262.80%18.33M
-28.69%-9.5M
-1,378.60%-81.96M
-1,132.57%-49.12M
Financing cash flow
Cash flow from continuing financing activities
10,708.70%2.44M
0
0
-99.34%779K
-36.53%556K
95.26%-23K
-99.76%281K
92.31%-35K
73.23%118.55M
3,708.70%876K
Net issuance payments of debt
10,665.22%2.43M
--0
--0
-102.09%-108K
---23K
---23K
-100.52%-27K
---35K
--5.18M
--0
Net common stock issuance
----
----
----
-29.67%512K
--204K
----
----
----
--728K
----
Proceeds from stock option exercised by employees
----
----
----
-44.20%375K
----
----
----
----
-55.20%672K
277.50%151K
Net other financing activities
----
----
----
----
----
----
----
----
658,782.35%111.98M
---3K
Cash from discontinued financing activities
Financing cash flow
10,708.70%2.44M
--0
--0
-99.34%779K
-36.53%556K
95.26%-23K
-99.76%281K
92.31%-35K
73.23%118.55M
3,708.70%876K
Net cash flow
Beginning cash position
-51.59%19.41M
-21.05%27.75M
-35.32%39.45M
2.86%60.99M
-61.24%45.83M
-71.98%40.09M
-15.09%35.15M
2.86%60.99M
91.05%59.29M
57.18%118.24M
Current changes in cash
-193.48%-5.37M
-269.03%-8.35M
54.73%-11.7M
-1,369.99%-21.54M
88.86%-6.38M
123.12%5.74M
-95.14%4.94M
-44.38%-25.84M
-94.00%1.7M
-259.30%-57.25M
End cash Position
-69.36%14.04M
-51.59%19.41M
-21.05%27.75M
-35.32%39.45M
-35.32%39.45M
-61.24%45.83M
-71.98%40.09M
-15.09%35.15M
2.86%60.99M
2.86%60.99M
Free cash flow
54.37%-7.87M
51.89%-8.35M
48.72%-11.7M
15.52%-64.43M
59.86%-7.04M
29.17%-17.24M
-2.29%-17.34M
-30.80%-22.81M
-89.83%-76.27M
-9.92%-17.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.85%-7.87M38.98%-8.35M28.35%-11.68M-50.15%-52.4M21.86%-7.04M-51.73%-15.38M-140.12%-13.68M-62.08%-16.3M-0.75%-34.9M24.77%-9.01M
Net income from continuing operations -93.43%-28.87M40.08%-11.2M35.31%-12.11M-22.05%-71.06M-2.71%-18.72M10.32%-14.92M-61.85%-18.7M-58.55%-18.72M-5.25%-58.22M-67.11%-18.22M
Operating gains losses ---2.35M---------1,596.04%-21.86M--5.63M---------------1.29M--0
Depreciation and amortization -19.34%1.46M21.14%1.47M57.27%1.46M38.49%5.43M56.14%1.47M76.04%1.82M29.52%1.21M-8.02%929K30.23%3.92M-8.70%944K
Other non cash items 10,020.56%17.86M3,073.17%3.66M-2,551.69%-2.36M45.90%-5.2M-357.56%-4.81M-161.02%-180K---123K---89K-165.21%-9.61M---1.05M
Change In working capital 622.64%3.05M171.02%2.39M104.34%70K-66.45%4.67M17.39%5.98M-120.19%-583K-84.97%880K-2,543.94%-1.61M2,160.81%13.9M278.83%5.1M
-Change in receivables 98.15%-40K-183.42%-166K115.56%21K-609.16%-929K401.72%1.16M-690.11%-2.16M239.16%199K-354.72%-135K66.84%-131K564.00%232K
-Change in prepaid assets 186.37%4.14M948.26%4.21M1,015.17%3.68M468.20%4.79M525.98%3.35M410.75%1.45M140.57%402K-5.51%-402K20.71%-1.3M977.05%535K
-Change in payables and accrued expense -93.79%29K-266.94%-616K-63.28%-2.56M-80.99%426K75.15%1.16M-59.18%467K-81.68%369K0.70%-1.57M14.51%2.24M130.34%660K
-Change in other current liabilities -12.27%-1.03M-742.48%-983K-207.26%-946K-96.57%484K-87.53%370K-128.64%-921K-97.23%153K-63.61%882K1,342.66%14.13M1,920.86%2.97M
-Change in other working capital -107.89%-46K73.66%-64K67.60%-127K89.35%-110K-108.29%-58K179.43%583K55.49%-243K13.47%-392K-156.39%-1.03M275.00%700K
Cash from discontinued investing activities
Operating cash flow 48.85%-7.87M38.98%-8.35M28.35%-11.68M-50.15%-52.4M21.86%-7.04M-51.73%-15.38M-140.12%-13.68M-62.08%-16.3M-0.75%-34.9M24.77%-9.01M
Investing cash flow
Cash flow from continuing investing activities -99.72%60K099.84%-15K136.70%30.08M100.21%101K248.88%21.14M262.80%18.33M-28.69%-9.5M-1,378.60%-81.96M-1,132.57%-49.12M
Net PPE purchase and sale 103.23%60K--099.77%-15K71.16%-11.93M101.18%101K86.92%-1.86M67.42%-3.67M11.83%-6.51M-646.42%-41.37M-114.13%-8.53M
Net investment purchase and sale --0--0--0203.51%42.01M--0--23M--22M---2.99M---40.59M---40.59M
Cash from discontinued investing activities
Investing cash flow -99.72%60K--099.84%-15K136.70%30.08M100.21%101K248.88%21.14M262.80%18.33M-28.69%-9.5M-1,378.60%-81.96M-1,132.57%-49.12M
Financing cash flow
Cash flow from continuing financing activities 10,708.70%2.44M00-99.34%779K-36.53%556K95.26%-23K-99.76%281K92.31%-35K73.23%118.55M3,708.70%876K
Net issuance payments of debt 10,665.22%2.43M--0--0-102.09%-108K---23K---23K-100.52%-27K---35K--5.18M--0
Net common stock issuance -------------29.67%512K--204K--------------728K----
Proceeds from stock option exercised by employees -------------44.20%375K-----------------55.20%672K277.50%151K
Net other financing activities --------------------------------658,782.35%111.98M---3K
Cash from discontinued financing activities
Financing cash flow 10,708.70%2.44M--0--0-99.34%779K-36.53%556K95.26%-23K-99.76%281K92.31%-35K73.23%118.55M3,708.70%876K
Net cash flow
Beginning cash position -51.59%19.41M-21.05%27.75M-35.32%39.45M2.86%60.99M-61.24%45.83M-71.98%40.09M-15.09%35.15M2.86%60.99M91.05%59.29M57.18%118.24M
Current changes in cash -193.48%-5.37M-269.03%-8.35M54.73%-11.7M-1,369.99%-21.54M88.86%-6.38M123.12%5.74M-95.14%4.94M-44.38%-25.84M-94.00%1.7M-259.30%-57.25M
End cash Position -69.36%14.04M-51.59%19.41M-21.05%27.75M-35.32%39.45M-35.32%39.45M-61.24%45.83M-71.98%40.09M-15.09%35.15M2.86%60.99M2.86%60.99M
Free cash flow 54.37%-7.87M51.89%-8.35M48.72%-11.7M15.52%-64.43M59.86%-7.04M29.17%-17.24M-2.29%-17.34M-30.80%-22.81M-89.83%-76.27M-9.92%-17.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data